Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Phyto

Phyto
2013 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Accelerator/Inc LATEST DEAL TYPE
4 INVESTORS
Description

Manufacturer of plant-based salt designed to reduce sodium intake. The company's salt is derived from Salicornia, a plant grown by seawater, enabling consumers to consume them to reduce high blood pressure and body fat.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Food Products
Other Industries
Agricultural Chemicals
Primary Office
  • 2nd Floor
  • Institute of Molecular Biology and Genetics, Seoul National University
  • Seoul
  • South Korea
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Phyto’s full profile, request a free trial.

Phyto Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 11-Sep-2019 Completed Generating Revenue
1. Early Stage VC 28-Apr-2014 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Phyto Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Terra Accelerator Accelerator/Incubator 000 0000 000000 0
Hanwha Investment Corporate Venture Capital Minority 000 0000 000000 0
Korea-Seoul Life Science Fund Venture Capital Minority 000 0000 000000 0
Oxford Bioscience Partners Venture Capital Minority 000 0000 000000 0

Phyto Executive Team (5)

Name Title Board
Seat
Contact
Info
Deuk-Hoi Kim Founder & Chief Executive Officer
Eun Ah Cho Co-Inventor
Hyun Joo Yoon Co-Inventor
Mee Hyang Kweon Co-Inventor
Seon Yeong Park Co-Inventor